Nocturnal Enuresis Clinical Trial
Official title:
Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study at Home - Differences Between Monosymptomatic Nocturnal Enuresis Patients and Healthy Controls
Full ambulatory polysomnography at home performed two nights in 30 healthy children and one
night in 30 children with mono-symptomatic nocturnal enuresis (15 with polyuria and 15
without polyuria). The children will be aged 7-14 years of age.
The sleep will be evaluated on sleep quality, number of periodic limb movements per hour,
blood pressure and pulse, beat to beat variation by electrocardiography during sleep,
respiration during sleep, nocturnal urine production, and enuresis episodes.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 7 Years to 14 Years |
Eligibility |
Inclusion Criteria: - 7-14 years of age - Normal objective evaluation including blood pressure - For healthy controls achieved continence both day and night before the age of 5. - For children with nocturnal enuresis at least 3 wet nights per week. - For children with enuresis clinical characteristics and at least one week of home recordings of nocturnal urine production and two days of full recording of fluid intake and urine production. Exclusion Criteria: - Obstipation (according to ROM IV criteria) - Day incontinence or severe urgency - Insomnia or known sleep disorders such as sleep walking, heavy snoring, night terrors or abnormal circadian rhythm. - Present or former deceases in the urinary tract, liver or in the endocrinological system. - Hypertension - Treatment with medication at the time of the study - ADHD, autism or other psychiatric disorders. |
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital | Aarhus | Aarhus N |
Lead Sponsor | Collaborator |
---|---|
University of Aarhus |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sleep efficiency | Sleep efficiency will be calculated as the ratio of the total time spent asleep to the total time spent in bed | One night of polysomnography. | |
Secondary | Periodic limb movements during sleep | Number of periodic limb movements per hour at sleep compared between the three groups. | One night of polysomnography. | |
Secondary | Nocturnal urine production | We will compare the nocturnal urine production in millilitres in the three groups. | One night of polysomnography. | |
Secondary | Enuresis episodes | We are going to look at the time of the enuresis episode and compare it to the polysomnographic findings at that time. | One night of polysomnography | |
Secondary | Respiratory events during sleep | Respiration during sleep comparison between the three groups. This includes saturation, nasal air flow and movement of the stomach and chest. Together showing the number of respiratory events (apneas/hour). | One night of polysomnography | |
Secondary | Incidence of sleep disturbances | Percentage of children with clinical sleep disturbances between patients and controls | One night of polysomnography | |
Secondary | Intra-individual differences in sleep efficiency from night to night in healthy controls. | Sleep efficiency (in percent) will be compared between the two nights of polysomnography in the healthy controls. | Two nights of polysomnography. Each evaluated after completing the two nights. | |
Secondary | Intra-individual differences in periodic limb movements during sleep from night to night in healthy controls. | Periodic limb movements during sleep will be compared between the two nights of polysomnography in the healthy controls. | Two nights of polysomnography. Each evaluated after completing the two nights. | |
Secondary | Intra-individual differences in nocturnal urine production from night to night in healthy controls. | Nocturnal urine production will be compared between the two study nights in the healthy controls. | Two nights of polysomnography. Each evaluated after completing the two nights. | |
Secondary | Intra-individual differences in respiratory events from night to night in healthy controls. | The number and kinds of respiratory events will be compared between the two study nights in the healthy controls. | Two nights of polysomnography. Each evaluated after completing the two nights. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02600676 -
Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis
|
N/A | |
Completed |
NCT04191863 -
Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.
|
||
Recruiting |
NCT03199508 -
Clinical Values of Voiding Diary for Diagnosis and Treatment for Monosymptomatic Enuresis in Children
|
N/A | |
Enrolling by invitation |
NCT05710718 -
PureWick⢠France and U.S. At-Home Pilot Study
|
N/A | |
Recruiting |
NCT06135311 -
Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children
|
N/A | |
Completed |
NCT03047720 -
Scheduled Awakenings for the Treatment of Nocturnal Enuresis
|
N/A | |
Recruiting |
NCT05617664 -
Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis
|
N/A | |
Completed |
NCT02328092 -
A Double-blind Randomized Clinical Trial on the Efficacy of Magnetic Sacral Roots Stimulation for the Treatment of NE
|
N/A | |
Completed |
NCT02068560 -
The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
|
N/A | |
Withdrawn |
NCT02337413 -
Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis
|
Phase 4 | |
Completed |
NCT01368913 -
MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis
|
N/A | |
Terminated |
NCT04420585 -
Desmopressin for Bedwetting in Children With SCD
|
Phase 4 | |
Completed |
NCT02538302 -
Minirin Versus Oxybutynin for Nocturnal Enuresis in Children
|
Phase 3 | |
Recruiting |
NCT04676139 -
The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in Children
|
Phase 3 | |
Completed |
NCT03812094 -
Basic Bladder Advice and Alarm Therapy in Nocturnal Enuresis
|
N/A | |
Completed |
NCT02178826 -
Nocturnal Enuresis and Rapid Maxillary Expansion
|
N/A | |
Recruiting |
NCT01575678 -
The Effect of Melatonin on Nocturnal Enuresis
|
Phase 2 | |
Completed |
NCT01078753 -
Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
|
Phase 3 | |
Recruiting |
NCT04313192 -
TENS Treatment for Bedwetting
|
N/A | |
Completed |
NCT05178641 -
Overnight Pant Study for Children With Nocturnal Enuresis
|
N/A |